Literature DB >> 15504883

Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.

Xinying Li1, Noriel Mariano, James J Rahal, Carl M Urban, Karl Drlica.   

Abstract

Stepwise selection of ciprofloxacin-resistant Haemophilus influenzae mutants produced first-, second-, third-, and fourth-step substitutions in GyrA (S84Y), ParC (S84R), GyrA (D88N), and ParC (E88K), respectively. Successive mutations raised the mutant selection window. The wild-type selection window for garenoxacin, levofloxacin, and moxifloxacin was also measured.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15504883      PMCID： PMC525419          DOI： 10.1128/AAC.48.11.4460-4462.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.

Authors:  Xinying Li; Xilin Zhao; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.

Authors:  M Yasuda; H Fukuda; S Yokoi; S Ishihara; Y Kawada; T Deguchi
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

3.  Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacin.

Authors:  J Vila; J Ruiz; F Sanchez; F Navarro; B Mirelis; M T de Anta; G Prats
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.

Authors:  T A Davies; L M Kelly; D B Hoellman; L M Ednie; C L Clark; S Bajaksouzian; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis.

Authors:  Y Dong; X Zhao; B N Kreiswirth; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 6.  Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.

Authors:  X Zhao; K Drlica
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

Review 7.  Pathogenesis and pathology of COPD.

Authors:  G Turato; R Zuin; M Saetta
Journal:  Respiration       Date:  2001       Impact factor: 3.580

Review 8.  Fluoroquinolones: action and resistance.

Authors:  Karl Drlica; Muhammad Malik
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

9.  Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program.

Authors:  Douglas J Biedenbach; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-05       Impact factor: 2.803

10.  Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance.

Authors:  María Pérez-Vázquez; Federico Román; M Carmen Varela; Rafael Cantón; José Campos
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790
View more
  17 in total

1.  Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenzae.

Authors:  Shigeki Nakamura; Katsunori Yanagihara; Yoshitomo Morinaga; Koichi Izumikawa; Masafumi Seki; Hiroshi Kakeya; Yoshihiro Yamamoto; Shimeru Kamihira; Shigeru Kohno
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

2.  Soft sweep development of resistance in Escherichia coli under fluoroquinolone stress.

Authors:  Xianxing Xie; Ruichen Lv; Chao Yang; Yajun Song; Yanfeng Yan; Yujun Cui; Ruifu Yang
Journal:  J Microbiol       Date:  2019-09-25       Impact factor: 3.422

3.  Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.

Authors:  H-G Wetzstein
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.

Authors:  Sebastian Bruchmann; Andreas Dötsch; Bianka Nouri; Iris F Chaberny; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

5.  Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.

Authors:  Carmen Puig; José Manuel Tirado-Vélez; Laura Calatayud; Fe Tubau; Junkal Garmendia; Carmen Ardanuy; Sara Marti; Adela G de la Campa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

6.  Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation.

Authors:  Yusuke Tanigawara; Kenji Nozawa; Hisatsugu Tsuda
Journal:  Eur J Clin Pharmacol       Date:  2011-07-28       Impact factor: 2.953

Review 7.  Drug interactions and the evolution of antibiotic resistance.

Authors:  Pamela J Yeh; Matthew J Hegreness; Aviva Presser Aiden; Roy Kishony
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

8.  Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.

Authors:  Melinda M Pettigrew; Brian T Tsuji; Janneane F Gent; Yong Kong; Patricia N Holden; Sanjay Sethi; Timothy F Murphy
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  The Inactivation of intrinsic antibiotic resistance determinants widens the mutant selection window for quinolones in Stenotrophomonas maltophilia.

Authors:  Guillermo García-León; María B Sánchez; José L Martínez
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

10.  Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.

Authors:  Sonia K Morgan-Linnell; Lynn Zechiedrich
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.